Drug intelligence / Profile preview

Valerian Extract Capsules

Development stage: Unknown
Lead developer: Wuhan United Pharmacy
Modality: Small Molecules
Administration: Oral

Overview

Valerian Extract Capsules is a modern Traditional Chinese Medicine (TCM) pharmaceutical developed and manufactured by Wuhan United Pharmacy. Formulated as an oral capsule, it contains a standardized plant extract derived from valerian, specifically characterized by its content of sesquiterpene lactone compounds. These small molecule constituents are reported to provide sedative, antispasmodic, and analgesic effects, and may also influence gastrointestinal motility. The drug is primarily indicated for the treatment of sleep disorders and for providing sedation. It has been approved in China as a Class 2 TCM New Drug.

Other names: 缬草提取物胶囊Valerian extract

Beyond the preview

Go deeper on Valerian Extract Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valerian Extract Capsules.

Explore the full profile